
    
      This is a prospective, open-label, single-arm study of patients diagnosed with vertebrogenic
      low back pain for a minimum of 6 months with conservative care. Participants will receive the
      Intracept System procedure to ablate the basivertebral nerve within the vertebral body.
      Treatment is performed on all vertebral bodies with Modic type 1 or type 2 changes on MRI
      from L3-S1.
    
  